{"schema_version":"secwatch.filing_event.v1","accession":"0001699350-26-000021","form_type":"8-K","ticker":"SI","cik":"0001699350","company_name":"SHOULDER INNOVATIONS, INC.","filed_at":"2026-04-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.764304+00:00","generated_at":"2026-05-15T03:52:52.248844+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Shoulder Innovations launches InSet I-135RFX Humeral Stem with expanded fracture indications","bullets":["Full commercial launch of InSet I-135RFX Humeral Stem after limited market release and FDA 510(k) clearance for fracture indications.","Product now indicated for primary, revision, and fracture total shoulder arthroplasty.","Third addition to I-Series humeral stem line in three years, following InSet 95 (2024) and InSet 70 (2025).","CEO Rob Ball says launch supports full spectrum of shoulder arthroplasty procedures.","Built on InSet lateral-lateral implant philosophy shown to reduce complications and improve range of motion."],"urls":{"canonical":"https://secwatch.observer/filing/0001699350-26-000021","json":"https://secwatch.observer/filing/0001699350-26-000021.json","markdown":"https://secwatch.observer/filing/0001699350-26-000021.md","text":"https://secwatch.observer/filing/0001699350-26-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1699350/000169935026000021/0001699350-26-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1699350/000169935026000021/si-20260427.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T03:52:52.248844+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}